메뉴 건너뛰기




Volumn 169, Issue 1-3, 2015, Pages 255-261

Akathisia: Prevalence and risk factors in a community-dwelling sample of patients with schizophrenia. Results from the FACE-SZ dataset

(56)  Berna, F a,g   Misdrahi, D a,e,f,p   Boyer, L a,d   Aouizerate, B a,e,f,o   Brunel, L a,b,c   Capdevielle, D a,h   Chereau, I a,i   Danion, J M a,g,h   Dorey, J M a,j,l   Dubertret, C a,k   Dubreucq, J a,l   Faget, C a,m   Gabayet, F a,f,l   Lancon, C a,m   Mallet, J a,k   Rey, R a,j   Passerieux, C a,m,n   Schandrin, A a,h   Schurhoff, F a,b,c   Tronche, A M a,i   more..


Author keywords

Akathisia; Anticholinergic drug; Antidepressant; Antipsychotic; Benzodiazepine; Schizophrenia

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; FIRST GENERATION ANTIPSYCHOTIC; NEUROLEPTIC AGENT; SECOND GENERATION ANTIPSYCHOTIC; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG;

EID: 84953739974     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2015.10.040     Document Type: Article
Times cited : (42)

References (48)
  • 2
    • 0024358369 scopus 로고
    • A rating scale for drug-induced akathisia
    • Barnes T.R. A rating scale for drug-induced akathisia. Br. J. Psychiatry 1989, 154:672-676.
    • (1989) Br. J. Psychiatry , vol.154 , pp. 672-676
    • Barnes, T.R.1
  • 3
    • 0022356785 scopus 로고
    • Akathisia variants and tardive dyskinesia
    • Barnes T.R., Braude W.M. Akathisia variants and tardive dyskinesia. Arch. Gen. Psychiatry 1985, 42:874-878.
    • (1985) Arch. Gen. Psychiatry , vol.42 , pp. 874-878
    • Barnes, T.R.1    Braude, W.M.2
  • 4
    • 36749015768 scopus 로고    scopus 로고
    • Chronic restlessness with antipsychotics
    • Bratti I.M., Kane J.M., Marder S.R. Chronic restlessness with antipsychotics. Am. J. Psychiatry 2007, 164:1648-1654. 10.1176/appi.ajp.2007.07071150.
    • (2007) Am. J. Psychiatry , vol.164 , pp. 1648-1654
    • Bratti, I.M.1    Kane, J.M.2    Marder, S.R.3
  • 5
    • 39949083383 scopus 로고    scopus 로고
    • The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder
    • Byerly M.J., Nakonezny P.A., Rush A.J. The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder. Schizophr. Res. 2008, 100:60-69. 10.1016/j.schres.2007.12.470.
    • (2008) Schizophr. Res. , vol.100 , pp. 60-69
    • Byerly, M.J.1    Nakonezny, P.A.2    Rush, A.J.3
  • 6
    • 33644769548 scopus 로고    scopus 로고
    • Increased risk of extrapyramidal side-effect treatment associated with atypical antipsychotic polytherapy
    • Carnahan R.M., Lund B.C., Perry P.J., Chrischilles E.A. Increased risk of extrapyramidal side-effect treatment associated with atypical antipsychotic polytherapy. Acta Psychiatr. Scand. 2006, 113:135-141. 10.1111/j.1600-0447.2005.00589.x.
    • (2006) Acta Psychiatr. Scand. , vol.113 , pp. 135-141
    • Carnahan, R.M.1    Lund, B.C.2    Perry, P.J.3    Chrischilles, E.A.4
  • 7
    • 78650251837 scopus 로고    scopus 로고
    • Movement disorders induced by antipsychotic drugs: implications of the CATIE schizophrenia trial
    • Caroff S.N., Hurford I., Lybrand J., Campbell E.C. Movement disorders induced by antipsychotic drugs: implications of the CATIE schizophrenia trial. Neurol. Clin. 2011, 29:127-148. 10.1016/j.ncl.2010.10.002.
    • (2011) Neurol. Clin. , vol.29 , pp. 127-148
    • Caroff, S.N.1    Hurford, I.2    Lybrand, J.3    Campbell, E.C.4
  • 8
    • 84865408349 scopus 로고    scopus 로고
    • Antipsychotic polypharmacy: a comprehensive evaluation of relevant correlates of a long-standing clinical practice
    • Correll C.U., Gallego J.A. Antipsychotic polypharmacy: a comprehensive evaluation of relevant correlates of a long-standing clinical practice. Psychiatr. Clin. N. Am. 2012, 35:661-681. 10.1016/j.psc.2012.06.007.
    • (2012) Psychiatr. Clin. N. Am. , vol.35 , pp. 661-681
    • Correll, C.U.1    Gallego, J.A.2
  • 9
    • 0026753733 scopus 로고
    • The significance of age of onset for schizophrenia
    • DeLisi L.E. The significance of age of onset for schizophrenia. Schizophr. Bull. 1992, 18:209-215.
    • (1992) Schizophr. Bull. , vol.18 , pp. 209-215
    • DeLisi, L.E.1
  • 10
    • 0034856344 scopus 로고    scopus 로고
    • Variables associated with disparities in treatment of patients with schizophrenia and comorbid mood and anxiety disorders
    • Dixon L., Green-Paden L., Delahanty J., Lucksted A., Postrado L., Hall J. Variables associated with disparities in treatment of patients with schizophrenia and comorbid mood and anxiety disorders. Psychiatr. Serv. 2001, 52:1216-1222.
    • (2001) Psychiatr. Serv. , vol.52 , pp. 1216-1222
    • Dixon, L.1    Green-Paden, L.2    Delahanty, J.3    Lucksted, A.4    Postrado, L.5    Hall, J.6
  • 12
    • 26844433208 scopus 로고    scopus 로고
    • Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
    • Faries D., Ascher-Svanum H., Zhu B., Correll C., Kane J. Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics. BMC Psychiatry 2005, 5:26. 10.1186/1471-244X-5-26.
    • (2005) BMC Psychiatry , vol.5 , pp. 26
    • Faries, D.1    Ascher-Svanum, H.2    Zhu, B.3    Correll, C.4    Kane, J.5
  • 16
    • 84866240639 scopus 로고    scopus 로고
    • Antipsychotic drugs and extrapyramidal side effects in first episode psychosis: a systematic review of head-head comparisons
    • Haddad P.M., Das A., Keyhani S., Chaudhry I.B. Antipsychotic drugs and extrapyramidal side effects in first episode psychosis: a systematic review of head-head comparisons. J. Psychopharmacol. 2012, 26:15-26. 10.1177/0269881111424929.
    • (2012) J. Psychopharmacol. , vol.26 , pp. 15-26
    • Haddad, P.M.1    Das, A.2    Keyhani, S.3    Chaudhry, I.B.4
  • 17
    • 0028297550 scopus 로고
    • Akathisia: prevalence and associated dysphoria in an in-patient population with chronic schizophrenia
    • Halstead S.M., Barnes T.R., Speller J.C. Akathisia: prevalence and associated dysphoria in an in-patient population with chronic schizophrenia. Br. J. Psychiatry 1994, 164:177-183.
    • (1994) Br. J. Psychiatry , vol.164 , pp. 177-183
    • Halstead, S.M.1    Barnes, T.R.2    Speller, J.C.3
  • 18
    • 84872356828 scopus 로고    scopus 로고
    • World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects
    • Hasan A., Falkai P., Wobrock T., Lieberman J., Glenthoj B., Gattaz W.F., Thibaut F., Möller H.-J., WFSBP Task force on Treatment Guidelines for Schizophrenia World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects. World J. Biol. Psychiatry 2013, 14:2-44. 10.3109/15622975.2012.739708.
    • (2013) World J. Biol. Psychiatry , vol.14 , pp. 2-44
    • Hasan, A.1    Falkai, P.2    Wobrock, T.3    Lieberman, J.4    Glenthoj, B.5    Gattaz, W.F.6    Thibaut, F.7    Möller, H.-J.8
  • 19
    • 1442264404 scopus 로고    scopus 로고
    • Prevalence of neuroleptic-induced movement disorders in chronic schizophrenia inpatients
    • Janno S., Holi M., Tuisku K., Wahlbeck K. Prevalence of neuroleptic-induced movement disorders in chronic schizophrenia inpatients. Am. J. Psychiatry 2004, 161:160-163.
    • (2004) Am. J. Psychiatry , vol.161 , pp. 160-163
    • Janno, S.1    Holi, M.2    Tuisku, K.3    Wahlbeck, K.4
  • 20
    • 9644279760 scopus 로고    scopus 로고
    • Actometry and Barnes Akathisia Rating Scale in neuroleptic-induced akathisia
    • Janno S., Holi M., Tuisku K., Wahlbeck K. Actometry and Barnes Akathisia Rating Scale in neuroleptic-induced akathisia. Eur. Neuropsychopharmacol. 2005, 15:39-41.
    • (2005) Eur. Neuropsychopharmacol. , vol.15 , pp. 39-41
    • Janno, S.1    Holi, M.2    Tuisku, K.3    Wahlbeck, K.4
  • 21
    • 77951165069 scopus 로고    scopus 로고
    • Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trials
    • Kane J.M., Barnes T.R.E., Correll C.U., Sachs G., Buckley P., Eudicone J., McQuade R., Tran Q.-V., Pikalov A., Assunção-Talbott S. Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trials. J. Psychopharmacol. 2010, 24:1019-1029. 10.1177/0269881109348157.
    • (2010) J. Psychopharmacol. , vol.24 , pp. 1019-1029
    • Kane, J.M.1    Barnes, T.R.E.2    Correll, C.U.3    Sachs, G.4    Buckley, P.5    Eudicone, J.6    McQuade, R.7    Tran, Q.-V.8    Pikalov, A.9    Assunção-Talbott, S.10
  • 23
    • 0023606101 scopus 로고
    • The positive and negative syndrome scale (PANSS) for schizophrenia
    • Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13:261-276.
    • (1987) Schizophr. Bull. , vol.13 , pp. 261-276
    • Kay, S.R.1    Fiszbein, A.2    Opler, L.A.3
  • 24
    • 0242326768 scopus 로고
    • Treatment of drug-induced extrapyramidal symptoms. (a comparative study of three antiparkinson agents)
    • Kruse W. Treatment of drug-induced extrapyramidal symptoms. (a comparative study of three antiparkinson agents). Dis. Nerv. Syst. 1960, 21:79-81.
    • (1960) Dis. Nerv. Syst. , vol.21 , pp. 79-81
    • Kruse, W.1
  • 25
    • 0031808720 scopus 로고    scopus 로고
    • SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment
    • Lane R.M. SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment. J. Psychopharmacol. 1998, 12:192-214.
    • (1998) J. Psychopharmacol. , vol.12 , pp. 192-214
    • Lane, R.M.1
  • 26
    • 58049157203 scopus 로고    scopus 로고
    • Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
    • Leucht S., Corves C., Arbter D., Engel R.R., Li C., Davis J.M. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 2009, 373:31-41. 10.1016/S0140-6736(08)61764-X.
    • (2009) Lancet , vol.373 , pp. 31-41
    • Leucht, S.1    Corves, C.2    Arbter, D.3    Engel, R.R.4    Li, C.5    Davis, J.M.6
  • 27
    • 84895767544 scopus 로고    scopus 로고
    • Dose equivalents for second-generation antipsychotics: the minimum effective dose method
    • Leucht S., Samara M., Heres S., Patel M.X., Woods S.W., Davis J.M. Dose equivalents for second-generation antipsychotics: the minimum effective dose method. Schizophr. Bull. 2014, 40:314-326. 10.1093/schbul/sbu001.
    • (2014) Schizophr. Bull. , vol.40 , pp. 314-326
    • Leucht, S.1    Samara, M.2    Heres, S.3    Patel, M.X.4    Woods, S.W.5    Davis, J.M.6
  • 28
    • 0038582771 scopus 로고    scopus 로고
    • New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis
    • Leucht S., Wahlbeck K., Hamann J., Kissling W. New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis. Lancet 2003, 361:1581-1589. 10.1016/S0140-6736(03)13306-5.
    • (2003) Lancet , vol.361 , pp. 1581-1589
    • Leucht, S.1    Wahlbeck, K.2    Hamann, J.3    Kissling, W.4
  • 31
    • 34247095585 scopus 로고    scopus 로고
    • On the relationship of atypical and low-dose conventional antipsychotics with akathisia in a clinical patient population
    • Markkula J., Helenius H., Lauerma H. On the relationship of atypical and low-dose conventional antipsychotics with akathisia in a clinical patient population. Nord. J. Psychiatry 2007, 61:152-157. 10.1080/08039480701226146.
    • (2007) Nord. J. Psychiatry , vol.61 , pp. 152-157
    • Markkula, J.1    Helenius, H.2    Lauerma, H.3
  • 32
    • 0033963172 scopus 로고    scopus 로고
    • Managing antipsychotic-induced acute and chronic akathisia
    • Miller C.H., Fleischhacker W.W. Managing antipsychotic-induced acute and chronic akathisia. Drug Saf. 2000, 22:73-81.
    • (2000) Drug Saf. , vol.22 , pp. 73-81
    • Miller, C.H.1    Fleischhacker, W.W.2
  • 34
    • 39849090320 scopus 로고    scopus 로고
    • Evolution of neuroleptic-induced extrapyramidal syndromes under long-term neuroleptic treatment
    • Modestin J., Wehrli M.V., Stephan P.L., Agarwalla P. Evolution of neuroleptic-induced extrapyramidal syndromes under long-term neuroleptic treatment. Schizophr. Res. 2008, 100:97-107. 10.1016/j.schres.2007.10.018.
    • (2008) Schizophr. Res. , vol.100 , pp. 97-107
    • Modestin, J.1    Wehrli, M.V.2    Stephan, P.L.3    Agarwalla, P.4
  • 35
    • 77957132243 scopus 로고    scopus 로고
    • Predictors of switching antipsychotic medications in the treatment of schizophrenia
    • Nyhuis A.W., Faries D.E., Ascher-Svanum H., Stauffer V.L., Kinon B.J. Predictors of switching antipsychotic medications in the treatment of schizophrenia. BMC Psychiatry 2010, 10:75. 10.1186/1471-244X-10-75.
    • (2010) BMC Psychiatry , vol.10 , pp. 75
    • Nyhuis, A.W.1    Faries, D.E.2    Ascher-Svanum, H.3    Stauffer, V.L.4    Kinon, B.J.5
  • 36
    • 0034026407 scopus 로고    scopus 로고
    • Benzodiazepines in schizophrenia. Is there a trend towards long-term prescribing?
    • Paton C., Banham S., Whitmore J. Benzodiazepines in schizophrenia. Is there a trend towards long-term prescribing?. Psychiatr. Bull. 2000, 24:113-115.
    • (2000) Psychiatr. Bull. , vol.24 , pp. 113-115
    • Paton, C.1    Banham, S.2    Whitmore, J.3
  • 37
    • 44949193763 scopus 로고    scopus 로고
    • High-dose and combination antipsychotic prescribing in acute adult wards in the UK: the challenges posed by p.r.n. prescribing
    • Paton C., Barnes T.R.E., Cavanagh M.-R., Taylor D., Lelliott P., POMH-UK project team High-dose and combination antipsychotic prescribing in acute adult wards in the UK: the challenges posed by p.r.n. prescribing. Br. J. Psychiatry 2008, 192:435-439. 10.1192/bjp.bp.107.042895.
    • (2008) Br. J. Psychiatry , vol.192 , pp. 435-439
    • Paton, C.1    Barnes, T.R.E.2    Cavanagh, M.-R.3    Taylor, D.4    Lelliott, P.5
  • 38
    • 84883856333 scopus 로고    scopus 로고
    • Audit of combination and high-dose antipsychotic treatment in the community
    • Rajan L., Clarke I. Audit of combination and high-dose antipsychotic treatment in the community. Psychiatrist 2013, 37:302-307.
    • (2013) Psychiatrist , vol.37 , pp. 302-307
    • Rajan, L.1    Clarke, I.2
  • 39
    • 77950168457 scopus 로고    scopus 로고
    • Anticholinergics for neuroleptic-induced acute akathisia
    • Rathbone J., Soares-Weiser K. Anticholinergics for neuroleptic-induced acute akathisia. Cochrane Database Syst. Rev. 2006, 10.1002/14651858.CD003727.pub3.
    • (2006) Cochrane Database Syst. Rev.
    • Rathbone, J.1    Soares-Weiser, K.2
  • 40
    • 84555186903 scopus 로고    scopus 로고
    • Second-generation antipsychotic drugs and extrapyramidal side effects: a systematic review and meta-analysis of head-to-head comparisons
    • Rummel-Kluge C., Komossa K., Schwarz S., Hunger H., Schmid F., Kissling W., Davis J.M., Leucht S. Second-generation antipsychotic drugs and extrapyramidal side effects: a systematic review and meta-analysis of head-to-head comparisons. Schizophr. Bull. 2012, 38:167-177. 10.1093/schbul/sbq042.
    • (2012) Schizophr. Bull. , vol.38 , pp. 167-177
    • Rummel-Kluge, C.1    Komossa, K.2    Schwarz, S.3    Hunger, H.4    Schmid, F.5    Kissling, W.6    Davis, J.M.7    Leucht, S.8
  • 41
    • 0029045649 scopus 로고
    • The epidemiology of drug-induced akathisia: part II. Chronic, tardive, and withdrawal akathisias
    • Sachdev P. The epidemiology of drug-induced akathisia: part II. Chronic, tardive, and withdrawal akathisias. Schizophr. Bull. 1995, 21:451-461.
    • (1995) Schizophr. Bull. , vol.21 , pp. 451-461
    • Sachdev, P.1
  • 43
    • 84941025095 scopus 로고    scopus 로고
    • A national network of schizophrenia expert centres: an innovative tool to bridge the research-practice gap
    • FondaMental Academic Centers of Expertise for Schizophrenia (FACE-SZ) collaborators
    • Schürhoff F., Fond G., Berna F., Bulzacka E., Vilain J., Capdevielle D., Misdrahi D., Leboyer M., Llorca P.-M. A national network of schizophrenia expert centres: an innovative tool to bridge the research-practice gap. Eur. Psychiatry 2015, 30:728-735. FondaMental Academic Centers of Expertise for Schizophrenia (FACE-SZ) collaborators.
    • (2015) Eur. Psychiatry , vol.30 , pp. 728-735
    • Schürhoff, F.1    Fond, G.2    Berna, F.3    Bulzacka, E.4    Vilain, J.5    Capdevielle, D.6    Misdrahi, D.7    Leboyer, M.8    Llorca, P.-M.9
  • 45
    • 43549111130 scopus 로고    scopus 로고
    • Acculturation is associated with the prevalence of tardive dyskinesia and akathisia in community-treated patients with schizophrenia
    • Sundram S., Lambert T., Piskulic D. Acculturation is associated with the prevalence of tardive dyskinesia and akathisia in community-treated patients with schizophrenia. Acta Psychiatr. Scand. 2008, 117:474-478. 10.1111/j.1600-0447.2008.01183.x.
    • (2008) Acta Psychiatr. Scand. , vol.117 , pp. 474-478
    • Sundram, S.1    Lambert, T.2    Piskulic, D.3
  • 46
    • 0018175277 scopus 로고
    • A rating scale for mania: reliability, validity and sensitivity
    • Young R.C., Biggs J.T., Ziegler V.E., Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry 1978, 133:429-435.
    • (1978) Br. J. Psychiatry , vol.133 , pp. 429-435
    • Young, R.C.1    Biggs, J.T.2    Ziegler, V.E.3    Meyer, D.A.4
  • 47
    • 84924965507 scopus 로고    scopus 로고
    • "First do no harm." A systematic review of the prevalence and management of antipsychotic adverse effects
    • Young S.L., Taylor M., Lawrie S.M. "First do no harm." A systematic review of the prevalence and management of antipsychotic adverse effects. J. Psychopharmacol. 2015, 29:353-362. 10.1177/0269881114562090.
    • (2015) J. Psychopharmacol. , vol.29 , pp. 353-362
    • Young, S.L.1    Taylor, M.2    Lawrie, S.M.3
  • 48
    • 84878877318 scopus 로고    scopus 로고
    • Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis
    • Zhang J.-P., Gallego J.A., Robinson D.G., Malhotra A.K., Kane J.M., Correll C.U. Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis. Int. J. Neuropsychopharmacol. 2013, 16:1205-1218. 10.1017/S1461145712001277.
    • (2013) Int. J. Neuropsychopharmacol. , vol.16 , pp. 1205-1218
    • Zhang, J.-P.1    Gallego, J.A.2    Robinson, D.G.3    Malhotra, A.K.4    Kane, J.M.5    Correll, C.U.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.